The effect of red yeast rice (Monascus purpureus) in dyslipidemia and other disorders - PubMed (original) (raw)
Review
The effect of red yeast rice (Monascus purpureus) in dyslipidemia and other disorders
Clinton W Yang et al. Complement Ther Med. 2012 Dec.
Abstract
Background: Red Yeast Rice (RYR) is a traditional Chinese food that is fermented and obtained after red yeast (Monascus purpureus) is grown on rice. RYR contains Monacolin K (Lovastatin) and other active ingredients that are thought to play a role in the management of cholesterol levels. Recently, many clinical trials have focused on the uses of RYR, including for dyslipidemia, coronary heart disease, diabetes, osteoporosis, cancer, non-alcoholic fatty liver disease, fatigue, and memory.
Objectives: The primary objective of this review is to evaluate the effectiveness of RYR on the management of dyslipidemia. The secondary objective is to review studies that focus on the other uses of RYR. The following search terms were used: red yeast rice, Xuezhikang, Hypocol, Cholestin, Monascus purpureus combined with dyslipidemia, hypercholesterolemia, hyperlipidemia, lipid, cardiovascular, coronary, atherosclerosis, diabetes, sugar, bone, osteoporosis, liver, fatigue, memory, Alzheimer's, dementia.
Results: Studies reviewed show that RYR significantly lowered LDL cholesterol and total cholesterol. Effects on triglycerides and HDL cholesterol were also observed in some studies. Compared with statins, RYR was shown to have an equal efficacy to statins when combined with or without other dietary supplements. RYR also appeared to be superior to placebo in preventing nonfatal myocardial infarction, total coronary heart disease events, and total deaths. On the other hand, information on diabetes, osteoporosis, cancer, non-alcoholic fatty liver disease, fatigue, and memory are currently limited although in vivo and in vitro studies have shown an effect.
Conclusion: Results of RYR clinical trials presented here have limitations and RYR's clinical use should be further investigated before using RYR as one of the alternative treatments for dyslipidemia management, despite the fact that the strongest evidence for RYR use is in dyslipidemia versus other clinical conditions.
Copyright © 2012 Elsevier Ltd. All rights reserved.
Similar articles
- Chinese red yeast rice (Monascus purpureus) for primary hyperlipidemia: a meta-analysis of randomized controlled trials.
Liu J, Zhang J, Shi Y, Grimsgaard S, Alraek T, Fønnebø V. Liu J, et al. Chin Med. 2006 Nov 23;1:4. doi: 10.1186/1749-8546-1-4. Chin Med. 2006. PMID: 17302963 Free PMC article. - Monascus purpureus-fermented Thai glutinous rice reduces blood and hepatic cholesterol and hepatic steatosis concentrations in diet-induced hypercholesterolemic rats.
Bunnoy A, Saenphet K, Lumyong S, Saenphet S, Chomdej S. Bunnoy A, et al. BMC Complement Altern Med. 2015 Mar 28;15:88. doi: 10.1186/s12906-015-0624-5. BMC Complement Altern Med. 2015. PMID: 25880551 Free PMC article. - Powdered red yeast rice and plant stanols and sterols to lower cholesterol.
Feuerstein JS, Bjerke WS. Feuerstein JS, et al. J Diet Suppl. 2012 Jun;9(2):110-5. doi: 10.3109/19390211.2012.682645. Epub 2012 Apr 25. J Diet Suppl. 2012. PMID: 22531006 Clinical Trial. - Functional food red yeast rice (RYR) for metabolic syndrome amelioration: a review on pros and cons.
Patel S. Patel S. World J Microbiol Biotechnol. 2016 May;32(5):87. doi: 10.1007/s11274-016-2035-2. Epub 2016 Apr 2. World J Microbiol Biotechnol. 2016. PMID: 27038957 Review. - Red Yeast Rice Plus Berberine: Practical Strategy for Promoting Vascular and Metabolic Health.
McCarty MF, O'Keefe JH, DiNicolantonio JJ. McCarty MF, et al. Altern Ther Health Med. 2015;21 Suppl 2:40-5. Altern Ther Health Med. 2015. PMID: 26308759 Review.
Cited by
- Evaluation the effects of red yeast rice in combination with statin on lipid profile and inflammatory indices; a randomized clinical trial.
Tavan A, Noroozi S, Zamiri B, Gholchin Vafa R, Rahmani M, Mehdizadeh Parizi M, Ahmadi A, Heydarzade R, Montaseri M, Hosseini SA, Kojuri J. Tavan A, et al. BMC Nutr. 2022 Nov 25;8(1):138. doi: 10.1186/s40795-022-00639-z. BMC Nutr. 2022. PMID: 36434733 Free PMC article. - Low Dose Monacolin K Combined with Coenzyme Q10, Grape Seed, and Olive Leaf Extracts Lowers LDL Cholesterol in Patients with Mild Dyslipidemia: A Multicenter, Randomized Controlled Trial.
Angelopoulos N, Paparodis RD, Androulakis I, Boniakos A, Argyrakopoulou G, Livadas S. Angelopoulos N, et al. Nutrients. 2023 Jun 9;15(12):2682. doi: 10.3390/nu15122682. Nutrients. 2023. PMID: 37375586 Free PMC article. Clinical Trial. - Nutraceuticals: Transformation of Conventional Foods into Health Promoters/Disease Preventers and Safety Considerations.
AlAli M, Alqubaisy M, Aljaafari MN, AlAli AO, Baqais L, Molouki A, Abushelaibi A, Lai KS, Lim SE. AlAli M, et al. Molecules. 2021 Apr 27;26(9):2540. doi: 10.3390/molecules26092540. Molecules. 2021. PMID: 33925346 Free PMC article. Review. - Effectiveness and Safety of Dietetic Supplementation of a New Nutraceutical on Lipid Profile and Serum Inflammation Biomarkers in Hypercholesterolemic Patients.
Riccioni G, Gammone MA, Currenti W, D'Orazio N. Riccioni G, et al. Molecules. 2018 May 14;23(5):1168. doi: 10.3390/molecules23051168. Molecules. 2018. PMID: 29757945 Free PMC article. - Red Yeast Rice Protects Circulating Bone Marrow-Derived Proangiogenic Cells against High-Glucose-Induced Senescence and Oxidative Stress: The Role of Heme Oxygenase-1.
Liu JT, Chen HY, Chen WC, Man KM, Chen YH. Liu JT, et al. Oxid Med Cell Longev. 2017;2017:3831750. doi: 10.1155/2017/3831750. Epub 2017 May 6. Oxid Med Cell Longev. 2017. PMID: 28555162 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical